PyIgClassify2: Canonical Clusters of Antibody CDR Loop Conformations

PyIgClassify2: Classification of Antibody CDR Conformations

CDRs for query 6WAR

#CDRs = 4; #Clusters = 4.
Chain	Gene	PDB Species	Frame Germline	Frame %	CDR Germline	CDR %	CDR	Length	Cluster	Distance(°)	Sequence	Ramachandran
B	heavy	Lama.glama	La_IGHV1S3*01_VHH	91.8	La_IGHV1S3*01_VHH	46.2	H1	13	H1-13-*	-1	VASGSIFSINAMD	BBBBABAABABBB
B	heavy	Lama.glama	La_IGHV1S3*01_VHH	91.8	La_IGHV1S3*01_VHH	88.9	H2	9	H2-9-1	14	GITSGGSTN	BBBAALBBB
B	heavy	Lama.glama	La_IGHV1S3*01_VHH	91.8	La_IGHV1S3*01_VHH	50.0	H3	14	H3-14-*	-1	AAEVGGWGPPRPDY	BBBBLBBEBBBBAB
B	heavy	Lama.glama	La_IGHV1S3*01_VHH	91.8	La_IGHV1S3*01_VHH	100.0	H4	8	H4-8-1	9	RDNAKNTV	BBAAALBB
D	heavy	Lama.glama	La_IGHV1S3*01_VHH	91.8	La_IGHV1S3*01_VHH	46.2	H1	13	H1-13-*	-1	VASGSIFSINAMD	BBBBABAABABBB
D	heavy	Lama.glama	La_IGHV1S3*01_VHH	91.8	La_IGHV1S3*01_VHH	88.9	H2	9	H2-9-1	13	GITSGGSTN	BBBAALBBB
D	heavy	Lama.glama	La_IGHV1S3*01_VHH	91.8	La_IGHV1S3*01_VHH	50.0	H3	14	H3-14-*	-1	AAEVGGWGPPRPDY	BBBBLBBEBBBBAB
D	heavy	Lama.glama	La_IGHV1S3*01_VHH	91.8	La_IGHV1S3*01_VHH	100.0	H4	8	H4-8-1	19	RDNAKNTV	BBAABLBB
F	heavy	Lama.glama	La_IGHV1S3*01_VHH	91.8	La_IGHV1S3*01_VHH	46.2	H1	13	H1-13-*	-1	VASGSIFSINAMD	BBBBABAABABBB
F	heavy	Lama.glama	La_IGHV1S3*01_VHH	91.8	La_IGHV1S3*01_VHH	88.9	H2	9	H2-9-1	14	GITSGGSTN	BBBAALBBB
F	heavy	Lama.glama	La_IGHV1S3*01_VHH	91.8	La_IGHV1S3*01_VHH	50.0	H3	14	H3-14-*	-1	AAEVGGWGPPRPDY	BBBBLBBEBBBBAB
F	heavy	Lama.glama	La_IGHV1S3*01_VHH	91.8	La_IGHV1S3*01_VHH	100.0	H4	8	H4-8-1	16	RDNAKNTV	BBAAALBB
H	heavy	Lama.glama	La_IGHV1S3*01_VHH	91.8	La_IGHV1S3*01_VHH	46.2	H1	13	H1-13-*	-1	VASGSIFSINAMD	BBBBABAABABBB
H	heavy	Lama.glama	La_IGHV1S3*01_VHH	91.8	La_IGHV1S3*01_VHH	88.9	H2	9	H2-9-1	13	GITSGGSTN	BBBAALBBB
H	heavy	Lama.glama	La_IGHV1S3*01_VHH	91.8	La_IGHV1S3*01_VHH	50.0	H3	14	H3-14-*	-1	AAEVGGWGPPRPDY	BBBBLBBEBBBBAB
H	heavy	Lama.glama	La_IGHV1S3*01_VHH	91.8	La_IGHV1S3*01_VHH	100.0	H4	8	H4-8-1	8	RDNAKNTV	BBAAALBB
J	heavy	Lama.glama	La_IGHV1S3*01_VHH	91.8	La_IGHV1S3*01_VHH	46.2	H1	13	H1-13-*	-1	VASGSIFSINAMD	BBBBABAABABBB
J	heavy	Lama.glama	La_IGHV1S3*01_VHH	91.8	La_IGHV1S3*01_VHH	88.9	H2	9	H2-9-1	14	GITSGGSTN	BBBAALBBB
J	heavy	Lama.glama	La_IGHV1S3*01_VHH	91.8	La_IGHV1S3*01_VHH	50.0	H3	14	H3-14-*	-1	AAEVGGWGPPRPDY	BBBBLBBEBBBBAB
J	heavy	Lama.glama	La_IGHV1S3*01_VHH	91.8	La_IGHV1S3*01_VHH	100.0	H4	8	H4-8-1	8	RDNAKNTV	BBAAALBB
L	heavy	Lama.glama	La_IGHV1S3*01_VHH	91.8	La_IGHV1S3*01_VHH	46.2	H1	13	H1-13-*	-1	VASGSIFSINAMD	BBBBABAABABBB
L	heavy	Lama.glama	La_IGHV1S3*01_VHH	91.8	La_IGHV1S3*01_VHH	88.9	H2	9	H2-9-1	13	GITSGGSTN	BBBAALBBB
L	heavy	Lama.glama	La_IGHV1S3*01_VHH	91.8	La_IGHV1S3*01_VHH	50.0	H3	14	H3-14-*	-1	AAEVGGWGPPRPDY	BBBBLBBEBBBBAB
L	heavy	Lama.glama	La_IGHV1S3*01_VHH	91.8	La_IGHV1S3*01_VHH	100.0	H4	8	H4-8-1	9	RDNAKNTV	BBAAALBB
N	heavy	Lama.glama	La_IGHV1S3*01_VHH	91.8	La_IGHV1S3*01_VHH	46.2	H1	13	H1-13-*	-1	VASGSIFSINAMD	BBBBABAABABBB
N	heavy	Lama.glama	La_IGHV1S3*01_VHH	91.8	La_IGHV1S3*01_VHH	88.9	H2	9	H2-9-1	14	GITSGGSTN	BBBAALBBB
N	heavy	Lama.glama	La_IGHV1S3*01_VHH	91.8	La_IGHV1S3*01_VHH	50.0	H3	14	H3-14-*	-1	AAEVGGWGPPRPDY	BBBBLBBEBBBBAB
N	heavy	Lama.glama	La_IGHV1S3*01_VHH	91.8	La_IGHV1S3*01_VHH	100.0	H4	8	H4-8-1	8	RDNAKNTV	BBAAALBB
P	heavy	Lama.glama	La_IGHV1S3*01_VHH	91.8	La_IGHV1S3*01_VHH	46.2	H1	13	H1-13-*	-1	VASGSIFSINAMD	BBBBABBABABBB
P	heavy	Lama.glama	La_IGHV1S3*01_VHH	91.8	La_IGHV1S3*01_VHH	88.9	H2	9	H2-9-1	14	GITSGGSTN	BBBAALBBB
P	heavy	Lama.glama	La_IGHV1S3*01_VHH	91.8	La_IGHV1S3*01_VHH	50.0	H3	14	H3-14-*	-1	AAEVGGWGPPRPDY	BBBBLBBEBBBBAB
P	heavy	Lama.glama	La_IGHV1S3*01_VHH	91.8	La_IGHV1S3*01_VHH	100.0	H4	8	H4-8-1	9	RDNAKNTV	BBAAALBB

Site developed by the Antibody Team at the lab of Roland Dunbrack. Last updated on Oct. 13, 2022